Differential Expression of Peroxiredoxins in Prostate Cancer: Consistent Upregulation of PRDX3 and PRDX4

BACKGROUND: The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa. METHODS: Transcript expression of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Basu, Anamika, Banerjee, Hiya, Rojas, Heather, Martinez, Shannalee R., Roy, Sourav, Jia, Zhenyu, Lilly, Michael B., De León, Marino, Casiano, Carlos A.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107902/
https://ncbi.nlm.nih.gov/pubmed/21031435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21292
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires